Detection of Gastric Cancer through Advanced
Endoscopic Imaging Technology using CNN
Journal:
GRENZE International Journal of Engineering and Technology
Authors:
Shilpa B, Ashwini K Hegde, Chaithanya G Puthran, Jayaswi, Rachana
Volume:
10
Issue:
2
Grenze ID:
01.GIJET.10.2.135_1
Pages:
3610-3614
Abstract
As a major worldwide health concern, gastric cancer requires novel approach for
identification to enhance patient outcomes. To diagnose stomach cancer accurately, this study
investigates the integration of ML (using convolutional neural networks) with cutting-edge
endoscopic imaging technology. In gastrointestinal diagnostics, the combination of DL (deep
learning) with Narrow Band Imaging (NBI), Autofluorescence Imaging (AFI), and Confocal
Laser Endomicroscopy (CLE) constitutes a novel paradigm. With utilization of these
sophisticated endoscopic imaging technologies, anomalies suggestive of stomach cancer may be
more accurately assessed. Next, a dataset of annotated endoscopic pictures employed for training
Convolutional Neural Networks, a technique for picture recognition. By utilizing the wealth of
data offered by the most sophisticated medical imaging technology, the CNN gains the ability to
recognize minute patterns and characteristics linked to stomach cancer throughout training. To
determine if this approach works on new, untested scenarios, its performance is thoroughly
verified using an independent dataset. Given the excellent confirmation precision, clinical trials
on new endoscopic images may be conducted to further explore CNN's potential to support
endoscopists in real-time diagnosis. Additionally, the CNN reduces the possibility of an
individual's mistake during endoscopic exams and gives second viewpoint. In the long run,
additional studies and developments will be necessary to improve the correctness and efficacy of
CNN algorithms for the identification of stomach cancer. In summary, combining CNNs with
cutting-edge gastrointestinal imaging methods offers a potential new direction for spotting
stomach cancer.